Sensei Biotherapeutics to Participate in Upcoming Investor Conferences

<p>BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that Company management will participate in the following investor conferences in September 2023: Citi’s 18th Annual Biopharma ConferenceSeptember 5th-7thBoston, MA Wells Fargo’s 2023 Healthcare […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/sensei-biotherapeutics-to-participate-in-upcoming-investor-conferences/">Sensei Biotherapeutics to Participate in Upcoming Investor Conferences</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>